Volume | 229,506 |
|
|||||
News | - | ||||||
Day High | 1.63 | Low High |
|||||
Day Low | 1.48 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
UNITY Biotechnology Inc | UBX | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
1.51 | 1.48 | 1.63 | 1.63 | 1.48 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
801 | 229,506 | $ 1.55 | $ 355,138 | - | 1.42 - 3.82 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
19:59:13 | formt | 200 | $ 1.56 | USD |
UNITY Biotechnology Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
23.54M | 14.62M | - | 0 | -39.86M | -2.73 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
UNITY Biotechnology News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical UBX Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 1.42 | 1.63 | 1.42 | 1.47 | 38,910 | 0.14 | 9.86% |
1 Month | 1.51 | 1.67 | 1.42 | 1.52 | 50,625 | 0.05 | 3.31% |
3 Months | 1.66 | 1.70 | 1.42 | 1.55 | 64,493 | -0.10 | -6.02% |
6 Months | 1.95 | 2.0799 | 1.42 | 1.71 | 87,542 | -0.39 | -20.00% |
1 Year | 2.98 | 3.82 | 1.42 | 2.28 | 99,181 | -1.42 | -47.65% |
3 Years | 47.10 | 50.85 | 1.42 | 12.15 | 733,888 | -45.54 | -96.69% |
5 Years | 85.50 | 154.40 | 1.42 | 28.49 | 667,074 | -83.94 | -98.18% |
UNITY Biotechnology Description
Unity Biotechnology Inc designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells; and creating senolytic medicines. Its medicines target vulnerabilities unique to senescent cells to clear those cells from the human body while leaving normal cells unaffected. The firm focuses on age-associated diseases such as osteoarthritis, eye diseases, and pulmonary diseases. |